Prof. Dr. Karim Nayernia
CEO, International Center for Personalized Medicine, Germany
Title: Personalized Cell Therapy of cardiovascular diseases


Prof. Dr. Jürgen Hescheler

 Director, Institute for Neurophysiology, University of Cologne,Germany

Title: Personalized Medicine Based on Induced Pluripotent Stem Cells

Prof. Dr. Uwe Nixdorff

CEO, European Prevention Center, Germany

Title: What Is The Privative Potential or Genetic Analysis in Clinical Cardiology?

Prof. Dr. Jeffrey K. Mills

CEO, Medler Ferro Woodhouse & Mills, USA

Title: Protecting Personalized Medicine Innovation in Europe and the US: Challenges and Opportunities

Dr. med. Majd AlGhatrif

Head of Human Cardiovascular Studies (NIA), Johns Hopkins School of Medicine,USA

Title: Precious Medicine in Ambiguous Diseases Individualizing care in Age-Associated Cardiovascular Conditions

Prof. Dr. Joseph Loscalzo

Head of the Department of Medicine at Brigham & Women’s Hospital, Harvard Medical School, USA

Title: Network Medicine: A Path to Precision Cardiovascular Medicine

Dr. David A. Nelles

CEO of Tartan LLC, USA

Title:  “RNA-targeting Cas9 Corrects Molecular and Physiological Features of Myotonic Dystrophy Type I”

Dr. med. Elham Kayvanpour
Specialist, Institute of cardiomyopathies,University Hospital Heidelberg, Germany

Title: Towards Individualized Therapy of Ischemic and  Non-Ischemic Heart Failure Patients

Prof. Dr. Heribert Schunkert

Director, German Heart Centre, Munich,Germany
Title: Multiplicative Effects of CAD Risk Alleles


Prof. Dr. Grant Morahan

Head of Centre for Diabetes Research,University of Western Australia

Title:Genetic Risk Signatures Identifying People at Higher Risk of Cancer, Heart Attack and Other Diseases

Prof. Dr. Kewal K. Jain

CEO, Jain PharmaBiotech, Switzerland

Title: Integration of Biotechnologies for The Development of Personalized Medicine for Cardiovascular Disorders

Prof. Dr. Kewal K. Jain

CEO, Jain PharmaBiotech, Switzerland

Title: Personalized Drug Therapy and Integration with Individualized Therapy

Dr. Thomas Bauer

Business Development Director, Germany

Title: Personalized Medicine: Market considerations and aspects from a Start-Up perspective

Dr. Thomas Bauer

Business Development Director, Germany

Title: Biomarker identification and detection in personalized medicine using Flow-Induced Dispersion Analysis

Dr. Leo Kurian

Principal Investigator, Institute for Neurophysiology, university of Cologne,Germany

Title: Loss of Genomic Integrity Induced by Lysosphingolipid Imbalance Drives Ageing in the Heart


Luise–Rainer-Str. 6–12
40235 Düsseldorf/Germany

Phone: +49-152–2280-5939